Licensing by inflammatory cytokines abolishes heterogeneity of immunosuppressive function of mesenchymal stem cell population
When mesenchymal stem cells (MSC) are used for therapy of immunological pathologies, MSCs get into an inflammatory environment altering the effectiveness of the treatment. To establish the impact of environmental inflammatory factors on MSC's immunofunction in the mirror of intrinsic heterogeneity of mouse MSC population, individual MSC clones were generated and characterized. Adipogenic but not osteogenic differentiation and pro-angiogenic activity of five independent MSC cell lines were similar. Regarding osteogenic differentiation, clones MSC3 and MSC6 exhibited poorer capacity than MSC2, MSC4 and MSC5. To study the immunosuppressive heterogeneity, in vitro and in vivo experiments have been carried out using T-cell proliferation assay and delayed-type hypersensitivity (DTH) response, respectively. Remarkable difference was found between the clones in their ability to inhibit T-cell proliferation in the following order: MSC2≥MSC5>MSC4>MSC3>>MSC6. Nevertheless, the differences between the immunosuppressive activities of the individual clones disappeared upon pre-treatment of the cells with pro-inflammatory cytokines, a procedure called licensing. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Materials and Methods

Cell culture
Mesenchymal stem cells were isolated from bone marrow of one C57BL/6 mouse and characterized as described previously [18, 19] . The cells were cultured in DMEM (Gibco   ®   ) supplemented with 10% fetal bovine serum (FBS) (Gibco In some experiments, MSCs were pre-treated with a mixture of 100 ng/mL mouse recombinant IFN-γ (R&D Systems) and 50 ng/mL TNF-α (kindly provided by Duda E of HAS, BRC Hungary) [22] for 24 h then washed twice with CM and T-cell proliferation was tested as described above.
Western blot analysis
Mesenchymal stromal cells were lysed (10 7 MSCs/mL) in RIPA buffer containing 10 mM 
Induction of Delayed Type Hypersensitivity (DTH) response
Ovalbumin (1 mg/mL in PBS, Sigma-Aldrich) was emulsified at a 1 : 1 ratio in complete 
Statistical analysis
Statistical analysis was performed using one-way analysis of variance test (ANOVA) in Kruskal-Wallis test followed by Mann-Whitney test was used. Differences were considered statistically significant with a p value less than 0.05 (set at *p < 0.05, **p < 0.01, ***p < 0.001).
Results
Characterization of monoclonal MSC cell lines
Each clone expressed uniformly Sca-1, CD29, CD44, CD106 and CD119 ( Fig. 1 ) at similar degree and none of the clones expressed lineage specific markers CD11b and CD45 (Fig. 1) .
In vitro osteoblast differentiation was assayed with Alisarin Red S staining showing that MSC2, MSC4 and MSC5 exhibited strong, MSC3 and MSC6 weak in vitro osteoblast differentiation ( Fig. 2A) . During adipocyte differentiation, all MSC clones accumulated comparable amount of neutral lipids into intracellular lipid droplets (Fig. 2B, C) , indicating that these cells had similar adipogenic differentiation potential.
In vitro pro-angiogenic activity of MSC clones
We have previously reported that MSCs and H5V endothelial cells spontaneously arranged into vessel-like structures within 3 days of co-culture [19] . Moreover, deficiency in galectin-1, a pro-angiogenic lectin in MSCs resulted in reduced formation of pre-vascular structures [19] . To determine whether individual MSC clones supported similarly or differently the shaping of these structures, in vitro pro-angiogenic assays were performed with the monoclonal MSC cultures. While neither MSC clones nor H5V endothelial cells formed prevascular structures alone, co-culturing any of the clones with H5V resulted in arrangement into pre-vascular structures (Fig. 3A ) in similar extent (Fig. 3B ). (Fig. 3C) . Results of qPCR experiments (Fig. 3C) were validated by Western blot analysis of galectin-1 protein ( Supplementary Fig. S1 )
MSC clones vary in in vitro immunosuppressive activity
Immunomodulatory properties of MSC clones were assessed in vitro by analyzing their effect on Con A-activated T-cell proliferation. Proliferation of T-cells was robustfully diminished in the presence of MSC2, MSC4 and MSC5 while poorly inhibited by MSC3 and MSC6 (Fig.   4A , B). Differences were significant and the order of their inhibitory capacity was as follows:
Our aim was to determine whether variability between the clones regarding their inhibitory activity was reflected in the expression levels of immunomodulatory factors. Therefore, the expression levels of mRNAs encoding NOS2, PTGS2 responsible for the production of antiinflammatory mediators, NO and PGE2, respectively and IDO1 creating a tryptophan deprived environment were analyzed. Relative Nos2 mRNA level well coincided with anti-proliferative function of the clones as it was expressed at higher levels in MSC2, MSC5 (significant) and MSC4 (not significant) than in MSC3 and was undetectable in MSC6 (Fig. 5A) . Expression of Ptgs2 did not show any remarkable difference between the clones (Fig. 5B) . The two enzymes, NOS2 and PTGS2 seemed to be important in the inhibitory function of the most immunosuppressive clone MSC2. The inhibition of T-cell proliferation by MSC2 was blocked entirely with L-NMMA and partially with indomethacin, inhibitors of NOS2 and PTGS2, respectively (Fig. 6 , Unstimulated MSC). In contrast, the presence of these inhibitors did not affect the activity of the least immunosuppressive clone MSC6 (Fig. 6 , Unstimulated MSC). Fig. S2 ) and Lgals1 (Fig. 3C ) were similar and Ido1 mRNA expression couldn't be detected in any of the clones ( Supplementary Fig. S3A ).
To model the in vivo inflammatory environment in which MSCs act as anti-inflammatory cells, the monoclonal cell lines were pre-treated with Th1 type cytokines, IFN-γ and TNF-α and the effect of the licenced MSC on T-cell proliferation was analyzed. Licensing by proinflammatory cytokines, MSC3 and MSC6 clones, which exerted poor inhibitory activity, blocked the T-cell proliferation at similar extent to the clones with strong inhibition. In contrast, licensing was not or barely able to further enhance immunosuppressive activity of MSC2, MSC4
and MSC5 (Fig. 4C) . Expression of Nos2 gene largely increased in all clones to an equal level upon IFN-γ and TNF-α treatment. Nevertheless, the degree of elevation was the most remarkable in clones with poor inhibitory activity (Fig. 5A ). On the other hand, Ptgs2 expression was also upregulated in all clones, although much less than that of Nos2 gene (Fig. 5B) . Furthermore, unstimulated MSC clones didn't express Ido1, unless they were pre-activated with IFN-γ and TNF-α. Pro-inflammatory cytokine treatment triggered Ido1 mRNA expression as well ( Supplementary Fig. S3A ).
To Fig. S3B ) indicating that IDO1 did not participate in the immunosuppression by these clones.
Ovalbumin-induced Delayed Type Hypersensitivity (DTH) model supports in vitro findings
The effect of the most and least immunosuppressive MSC2 and MSC6 clones, respectively, was tested in ovalbumin-induced DTH response in mice. MSC2 significantly prevented the thickening of footpad while MSC6 injection resulted in no change compared to the control (treatment without MSCs) (Fig. 7) . Nevertheless, when pre-treated with IFN-γ and TNF-α prior to injection, MSC6 diminished DTH reaction similarly to non-treated MSC2 clone while immunosuppressive activity of MSC2 was not affected by licensing (data not shown). In addition, the data regarding heterogeneity in immunosuppressive properties of MSC population is insufficient and meets discrepancy. While Xu et al. argued that single cell-derived MSC populations possessed uniform immunomodulating capacities [14] others demonstrated large differences in immunosuppression at clonal level [15, 16] .
Discussion
In the present study, clonal diversity of murine bone marrow MSCs was examined with a special focus on the in vitro and in vivo immunosuppression. Moreover, in vitro osteoblast and adipocyte MSC5 strongly inhibited T-cell proliferation while inhibitory activities of MSC3 and MSC6 were significantly weaker. Our results were in accordance with those published by others [15, 16] reporting difference between the immunosuppressive activities of single cell-derived MSC clones. The diversity in the inhibition of T-cell proliferation could be explained by the different expression of immunomodulatory gene Nos2, responsible for the generation of a crucial mediator, NO. Elevated level of Nos2 expression was found in naïve MSC2, MSC4 and MSC5, the clones representing high inhibitory activity. Whereas it was expressed at a lower level or was undetectable in MSC3 and MSC6, respectively, the clones slightly inhibiting T-cell proliferation.
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